相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity
Alfredo G. Casanova et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The pharmacological properties of chrysophanol, the recent advances
Siyu Su et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway
Fang Dou et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway
Chuan Guo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
被撤回的出版物: Chrysophanol Suppresses Hypoxia-Induced Epithelial-Mesenchymal Transition in Colorectal Cancer Cells (Retracted article. See JUN, 2023)
Min Deng et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2019)
Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer
Marilia B. Visacri et al.
CANCER MEDICINE (2019)
Chrysophanol: a review of its pharmacology, toxicity and pharmacokinetics
Long Xie et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
The concurrent treatment of Scutellaria baicalensis Georgi enhances the therapeutic efficacy of cisplatin but also attenuates chemotherapy-induced cachexia and acute kidney injury
Tse-Hung Huang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Oxidative stress as a potential target in acute kidney injury
Anamaria Magdalena Tomsa et al.
PEERJ (2019)
Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
Jing Lu et al.
ACTA PHARMACEUTICA SINICA B (2019)
Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol
Alexandra R. Crowe et al.
BIO-PROTOCOL (2019)
Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis
Lauren P. Diebold et al.
NATURE METABOLISM (2019)
Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential
Prateeksha et al.
BIOMOLECULES (2019)
Cisplatin nephrotoxicity: a review of the literature
Sandhya Manohar et al.
JOURNAL OF NEPHROLOGY (2018)
NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation
Xiao-Ming Meng et al.
LABORATORY INVESTIGATION (2018)
Role of food-derived antioxidants against cisplatin induced-nephrotoxicity
Tania Gomez-Sierra et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis
Kosaku Nanki et al.
CELL (2018)
Protective Effect of Rheum turkestanicum against Cisplatin by Reducing Oxidative Stress in Kidney Tissue
Azar Hosseini et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2018)
Urinary neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, N-acetyl-β-D-glucosaminidase levels and mortality risk in septic patients with acute kidney injury
Heng Fan et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
Chrysophanol Suppressed Glutamate-Induced Hippocampal Neuronal Cell Death via Regulation of Dynamin-Related Protein 1-Dependent Mitochondrial Fission
Unbin Chae et al.
PHARMACOLOGY (2017)
Advances in bio-active constituents, pharmacology and clinical applications of rhubarb
Yu-Jie Cao et al.
CHINESE MEDICINE (2017)
The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice
Yonggang Lian et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Inhibition of Acute Lung Injury by TNFR-Fc through Regulation of an Inflammation-Oxidative Stress Pathway
Yuan Weifeng et al.
PLOS ONE (2016)
NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI)
Abdullah Ozkok et al.
TOXICOLOGY LETTERS (2016)
Protective effect of chrysophanol on LPS/D-GalN-induced hepatic injury through the RIP140/NF-κB pathway
Wenjiao Jiang et al.
RSC ADVANCES (2016)
Nox and renal disease
Chet E. Holterman et al.
CLINICAL SCIENCE (2015)
Nox-4 and progressive kidney disease
Vicki Thallas-Bonke et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70
Meng Qi et al.
PHARMACOLOGICAL RESEARCH (2015)
Chrysophanol-Induced Cell Death (Necrosis) in Human Lung Cancer A549 Cells Is Mediated Through Increasing Reactive Oxygen Species and Decreasing the Level of Mitochondrial Membrane Potential
Chien-Hang Ni et al.
ENVIRONMENTAL TOXICOLOGY (2014)
A novel GC-MS method for determination of chrysophanol in rat plasma and tissues: Application to the pharmacokinetics, tissue distribution and plasma protein binding studies
Qinhua Chen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Chrysophanol Inhibits NALP3 Inflammasome Activation and Ameliorates Cerebral Ischemia/Reperfusion in Mice
Nan Zhang et al.
MEDIATORS OF INFLAMMATION (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Ozkok et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Yves Gorin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Associations of Urinary Levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Kidney Function Decline in the Multi-Ethnic Study of Atherosclerosis (MESA)
Carmen A. Peralta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Role of Nox4 in murine models of kidney disease
Andrea Babelova et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Apoptosis and acute kidney injury
Andrea Havasi et al.
KIDNEY INTERNATIONAL (2011)
Chrysophanic Acid Blocks Proliferation of Colon Cancer Cells by Inhibiting EGFR/mTOR Pathway
Myung Sun Lee et al.
PHYTOTHERAPY RESEARCH (2011)
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
Yolanda I. Chirino et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2009)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Biomarkers for the early detection of acute kidney injury
Mai T. Nguyen et al.
PEDIATRIC NEPHROLOGY (2008)
Activation and involvement of p53 in cisplatin-induced nephrotoxicity
Qingqing Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Cisplatin nephrotoxicity: A review
Xin Yao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
N. A. G. Santos et al.
ARCHIVES OF TOXICOLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer
Stacy S. Shord et al.
ANTI-CANCER DRUGS (2006)
NADPH oxidases in the kidney
Pritmohinder S. Gill et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway
YJ Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
M Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Metabolism of cisplatin to a nephrotoxin in proximal tubule cells
DM Townsend et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
分享论文
